Cargando…

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats

The prevalence of metabolic syndrome has increased in modern society and the condition is proving to be a common precursor of cardiovascular disease. The aim of the present study was to investigate whether astragaloside IV, a major active constituent of Astragalus membranaceus (Fisch) Bge., is able...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ning, Wang, Xu-Hui, Mao, Shi-Long, Zhao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263341/ https://www.ncbi.nlm.nih.gov/pubmed/21555978 http://dx.doi.org/10.3390/molecules16053896

Ejemplares similares

Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats
por: Padiya, Raju, et al.
Publicado: (2011)

Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats
por: Chou, Chu-Lin, et al.
Publicado: (2011)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

α-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed Hamsters
por: Boa, Beatriz C. S., et al.
Publicado: (2015)

Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats
por: Nade, Vandana S., et al.
Publicado: (2012)

Proteomic changes associated with metabolic syndrome in a fructose-fed rat model
por: Hsieh, Cheng-Chu, et al.
Publicado: (2016)

Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats
por: Mao, Shuai, et al.
Publicado: (2016)

Astragaloside IV prevents endothelial dysfunction by improving oxidative stress in streptozotocin-induced diabetic mouse aortas
por: Zhang, Yang, et al.
Publicado: (2021)

Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism
por: Gao, Jian, et al.
Publicado: (2020)

Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome
por: Lin, Xin, et al.
Publicado: (2019)

Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats
por: Wang, Qiuning, et al.
Publicado: (2022)

Clerodendrum trichotomum extract improves metabolic derangements in high fructose diet-fed rats
por: Jang, Mi Gyeong, et al.
Publicado: (2021)

Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network
por: Wu, Hui, et al.
Publicado: (2016)

Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
por: Meng, Peipei, et al.
Publicado: (2021)

20-Hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats
por: Buniam, Jariya, et al.
Publicado: (2020)

Association of rat thoracic aorta dilatation by astragaloside IV with the generation of endothelium-derived hyperpolarizing factors and nitric oxide, and the blockade of Ca(2+) channels
por: HU, GUANYING, et al.
Publicado: (2016)

Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
por: Li, Liu-Cheng, et al.
Publicado: (2017)

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats
por: Sun, Sen, et al.
Publicado: (2022)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
por: Zhang, Zhen, et al.
Publicado: (2019)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism
por: Zhang, Huan, et al.
Publicado: (2020)

Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats
por: Shen, Fengyan, et al.
Publicado: (2022)

Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritis
por: ZHANG, Dong, et al.
Publicado: (2022)

Beneficial Effects of Calcitriol on Hypertension, Glucose Intolerance, Impairment of Endothelium-Dependent Vascular Relaxation, and Visceral Adiposity in Fructose-Fed Hypertensive Rats
por: Chou, Chu-Lin, et al.
Publicado: (2015)

Angiotensin 1-7 as Means to Prevent the Metabolic Syndrome: Lessons From the Fructose-Fed Rat Model
por: Marcus, Yonit, et al.
Publicado: (2013)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells
por: LU, YAO, et al.
Publicado: (2015)

Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure
por: Tang, Bin, et al.
Publicado: (2018)

Simvastatin-induced cardiac autonomic control improvement in fructose-fed female rats
por: da Silva, Renata Juliana, et al.
Publicado: (2011)

Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat
por: Unger, Banappa S., et al.
Publicado: (2009)

Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
por: Li, Lei, et al.
Publicado: (2023)

Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats
por: Chou, Chu-Lin, et al.
Publicado: (2017)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rppi8t5ieehtjmgf58uql1qt9l